{"id":919540,"date":"2025-12-15T08:04:15","date_gmt":"2025-12-15T13:04:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\/"},"modified":"2025-12-15T08:04:15","modified_gmt":"2025-12-15T13:04:15","slug":"mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\/","title":{"rendered":"MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13"},"content":{"rendered":"
\n

CARMEL, Ind., Dec. 15, 2025 (GLOBE NEWSWIRE) — MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that Kent Hawryluk, President and Chief Executive Officer, will present at and participate in the 44th<\/sup> Annual J.P. Morgan Healthcare Conference in San Francisco being held on\u00a0January 12-15, 2026.<\/p>\n

\n 44<\/strong>
\n
\n th<\/strong>
\n <\/sup>
\n Annual J.P. Morgan Healthcare Conference<\/strong>\n <\/p>\n

Date: Tuesday, January 13, 2026
Format: Company presentation and 1×1 meetings
Time: 3:45 p.m. PT\/ 6:45 p.m. ET
Location: San Francisco, California<\/p>\n

The live webcast can be accessed in the events section of the MBX Biosciences website at\u00a0https:\/\/investors.mbxbio.com\/news-events\/events<\/a>. Access to the webcast replay will be available approximately two hours after the completion of the events and will be archived on the Company\u2019s website for approximately 90 days.<\/p>\n

\n About\u00a0MBX Biosciences<\/strong>
\n
MBX Biosciences is a biopharmaceutical company focused on the discovery and development of novel precision peptide therapies based on its proprietary PEP\u2122 platform, for the treatment of endocrine and metabolic disorders. The Company is advancing a pipeline of novel candidates for endocrine and metabolic disorders with clinically validated targets, established endpoints for regulatory approval, significant unmet medical needs and large potential market opportunities. The Company\u2019s pipeline includes canvuparatide (MBX 2109) for the treatment of chronic hypoparathyroidism (HP) preparing for Phase 3 development; an obesity portfolio that includes MBX 4291 in Phase 1 development, as well as multiple discovery and pre-clinical obesity candidates; and imapextide (MBX 1416) for the treatment of post-bariatric hypoglycemia (PBH) in Phase 2 development. The Company is based in Carmel, Indiana. To learn more, please visit the Company website at\u00a0www.mbxbio.com<\/a>\u00a0and follow it on\u00a0LinkedIn<\/a>.<\/p>\n

\n Media Contact:<\/strong>
\n
Cassidy McClain
Inizio Evoke Comms
cassidy.mcclain@inizioevoke.com<\/a>
(619) 694-6291<\/p>\n

\n Investor Contact:<\/strong>
\n
Jim DeNike
MBX Biosciences
jdenike@mbxbio.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

CARMEL, Ind., Dec. 15, 2025 (GLOBE NEWSWIRE) — MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that Kent Hawryluk, President and Chief Executive Officer, will present at and participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco being held on\u00a0January 12-15, 2026. 44 th Annual J.P. Morgan Healthcare Conference Date: Tuesday, January 13, 2026Format: Company presentation and 1×1 meetingsTime: 3:45 p.m. PT\/ 6:45 p.m. ETLocation: San Francisco, California The live webcast can be accessed in the events section of the MBX Biosciences website at\u00a0https:\/\/investors.mbxbio.com\/news-events\/events. Access to the webcast replay will be available approximately two hours … <\/p>\n

Continue reading “MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-919540","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nMBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CARMEL, Ind., Dec. 15, 2025 (GLOBE NEWSWIRE) — MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that Kent Hawryluk, President and Chief Executive Officer, will present at and participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco being held on\u00a0January 12-15, 2026. 44 th Annual J.P. Morgan Healthcare Conference Date: Tuesday, January 13, 2026Format: Company presentation and 1×1 meetingsTime: 3:45 p.m. PT\/ 6:45 p.m. ETLocation: San Francisco, California The live webcast can be accessed in the events section of the MBX Biosciences website at\u00a0https:\/\/investors.mbxbio.com\/news-events\/events. Access to the webcast replay will be available approximately two hours … Continue reading "MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-15T13:04:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMDk3NSM3MzE4Mjk2IzIyNDUzNzQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13\",\"datePublished\":\"2025-12-15T13:04:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\\\/\"},\"wordCount\":315,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYwMDk3NSM3MzE4Mjk2IzIyNDUzNzQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\\\/\",\"name\":\"MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYwMDk3NSM3MzE4Mjk2IzIyNDUzNzQ=\",\"datePublished\":\"2025-12-15T13:04:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYwMDk3NSM3MzE4Mjk2IzIyNDUzNzQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYwMDk3NSM3MzE4Mjk2IzIyNDUzNzQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\/","og_locale":"en_US","og_type":"article","og_title":"MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13 - Market Newsdesk","og_description":"CARMEL, Ind., Dec. 15, 2025 (GLOBE NEWSWIRE) — MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that Kent Hawryluk, President and Chief Executive Officer, will present at and participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco being held on\u00a0January 12-15, 2026. 44 th Annual J.P. Morgan Healthcare Conference Date: Tuesday, January 13, 2026Format: Company presentation and 1×1 meetingsTime: 3:45 p.m. PT\/ 6:45 p.m. ETLocation: San Francisco, California The live webcast can be accessed in the events section of the MBX Biosciences website at\u00a0https:\/\/investors.mbxbio.com\/news-events\/events. Access to the webcast replay will be available approximately two hours … Continue reading \"MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\/","og_site_name":"Market Newsdesk","article_published_time":"2025-12-15T13:04:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMDk3NSM3MzE4Mjk2IzIyNDUzNzQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13","datePublished":"2025-12-15T13:04:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\/"},"wordCount":315,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMDk3NSM3MzE4Mjk2IzIyNDUzNzQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\/","name":"MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMDk3NSM3MzE4Mjk2IzIyNDUzNzQ=","datePublished":"2025-12-15T13:04:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMDk3NSM3MzE4Mjk2IzIyNDUzNzQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMDk3NSM3MzE4Mjk2IzIyNDUzNzQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mbx-biosciences-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference-on-january-13\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/919540","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=919540"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/919540\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=919540"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=919540"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=919540"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}